Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PARP/EZH2-IN-1 is a novel compound that functions as a dual inhibitor for both PARP (IC50 6.87 nM) and EZH2 (IC50 36.51 nM), showing promising potential for the treatment of triple-negative breast cancer with wild-type BRCA.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 970.00 |
Description | PARP/EZH2-IN-1 is a novel compound that functions as a dual inhibitor for both PARP (IC50 6.87 nM) and EZH2 (IC50 36.51 nM), showing promising potential for the treatment of triple-negative breast cancer with wild-type BRCA. |
Targets&IC50 | PARP1:6.87 nM (IC50), EZH2:36.51 nM (IC50) |
Synonyms | PARP/EZH2-IN-1 |
Molecular Weight | 768.85 |
Formula | C43H41FN8O5 |
CAS No. | 2687273-52-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PARP/EZH2-IN-1 2687273-52-3 PARP/EZH2 IN 1 PARP/EZH-2-IN-1 PARP/EZH2IN1 inhibitor inhibit